Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

584 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
FDA Approval Summary: Ivosidenib for Relapsed or Refractory Acute Myeloid Leukemia with an Isocitrate Dehydrogenase-1 Mutation.
Norsworthy KJ, Luo L, Hsu V, Gudi R, Dorff SE, Przepiorka D, Deisseroth A, Shen YL, Sheth CM, Charlab R, Williams GM, Goldberg KB, Farrell AT, Pazdur R. Norsworthy KJ, et al. Among authors: pazdur r. Clin Cancer Res. 2019 Jun 1;25(11):3205-3209. doi: 10.1158/1078-0432.CCR-18-3749. Epub 2019 Jan 28. Clin Cancer Res. 2019. PMID: 30692099
Conflicting phase II efficacy data for Doxil.
Frykman G, Williams G, Pazdur R. Frykman G, et al. Among authors: pazdur r. J Clin Oncol. 2001 Jan 15;19(2):596-7. doi: 10.1200/JCO.2001.19.2.596. J Clin Oncol. 2001. PMID: 11208859 No abstract available.
Developing drugs to decrease the toxicity of chemotherapy.
Williams G, Cortazar P, Pazdur R. Williams G, et al. Among authors: pazdur r. J Clin Oncol. 2001 Jul 15;19(14):3439-41. doi: 10.1200/JCO.2001.19.14.3439. J Clin Oncol. 2001. PMID: 11454894 No abstract available.
FDA drug approval summaries: fulvestrant.
Bross PF, Cohen MH, Williams GA, Pazdur R. Bross PF, et al. Among authors: pazdur r. Oncologist. 2002;7(6):477-80. doi: 10.1634/theoncologist.7-6-477. Oncologist. 2002. PMID: 12490735 Free article.
584 results